Galmed Pharmaceuticals

Next Generation of Metabolic and Inflammatory Therapeutics

Active Public Startup Tel Aviv-Yafo Founded 2000-01

Website ↗ LinkedIn

Galmed Pharmaceuticals is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. The company is also collaborating with the Hebrew University in the development of…